{"id":"W2790637078","doi":"10.1186/s12962-018-0089-8","title":"Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US","year":2018,"lang":"en","type":"article","venue":"Cost Effectiveness and Resource Allocation","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"University of British Columbia; Canadian Lung Association; Reseau canadien de recherche respiratoire; Canadian Thoracic Society; Institute of Circulatory and Respiratory Health; Michael Smith Health Research BC; GlaxoSmithKline; British Columbia Lung Association; Canadian Institutes of Health Research; AstraZeneca Canada; AstraZeneca","keywords":"Omalizumab; Medicine; Asthma; Tiotropium bromide; Quality-adjusted life year; Cost effectiveness; Intensive care medicine; Internal medicine; Pediatrics; Immunoglobulin E; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003890383,0.001048708,0.001701925,0.001203625,0.000295919,0.001393654,0.001062394,0.001461879,0.003608255],"category_scores_gemma":[0.01323669,0.0006690115,0.004663879,0.0007918231,0.0005359424,0.001291749,0.0008958285,0.001495366,0.0001252566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005802582,"about_ca_system_score_gemma":0.003694206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01558883,"about_ca_topic_score_gemma":0.009426738,"domain_scores_codex":[0.9982328,0.001191044,0.00009051592,0.0001200718,0.0001688027,0.0001966483],"domain_scores_gemma":[0.9965844,0.00242855,0.0005719756,0.00007126764,0.0001027427,0.0002408912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.1650562,0.003303346,0.04188848,0.002798052,0.01428104,0.0006569933,0.0001487525,0.6856904,0.002062608,0.006299165,0.003948036,0.07386704],"study_design_scores_gemma":[0.0398154,0.02955699,0.07132943,0.002338967,0.02824542,0.001075299,0.0004198579,0.805306,0.002946564,0.01406935,0.004662917,0.0002338217],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760489,0.01212927,0.002725148,0.002341119,0.0001508315,0.0006932422,0.001709679,0.00008792924,0.004113979],"genre_scores_gemma":[0.9973645,0.00104965,0.0006726834,0.0001972842,0.00001673457,0.0001770623,0.0003465562,0.000005959167,0.0001694995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01558883,"threshold_uncertainty_score":0.04210091,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02799356763001311,"score_gpt":0.3211294701530908,"score_spread":0.2931359025230777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}